The effect of combination of Descurainia Sophia and Deracocephalum syrup on patients with irritable bowel syndrome with constipatio
Phase 2
- Conditions
- irritable bowel syndrome.Irritable bowel syndrome without diarrheaK58.9
- Registration Number
- IRCT20220104053626N5
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
having IBS according to ROME IV criteria
age above 18
having normal colonoscopy within 5 years
willing to participate
Exclusion Criteria
pregnancy and lactation
any history of drug reaction
celiac disease
recent use of probiotics,laxatives,antibiotics and anti inflammatory drugs such as NSAID and corticosteroides.
history of inflammatory bowel disease( ulcerative colitis and crohn disease)
any pathologic findings in colonoscopy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients quality of life. Timepoint: Before and after the intervention. Method of measurement: The quality of life questionnaire for patients with irritable bowel syndrome.;Stool stiffness. Timepoint: before and after intervention. Method of measurement: Patient Assessment of Constipation–Symptom(PAC-SYM) questionnaire.
- Secondary Outcome Measures
Name Time Method